TrialJAMA network open2020

Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)-Positive Breast Cancer.

Natalia Kunst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.